Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000954362 | SCV001100990 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001593149 | SCV001824546 | likely benign | not provided | 2020-09-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001664572 | SCV001879731 | benign | not specified | 2021-03-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489321 | SCV002802495 | likely benign | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2022-03-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985468 | SCV004730320 | likely benign | CACNA1A-related disorder | 2024-01-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |